Blood News and Research

RSS

Strategy for capturing SARS-CoV-2 through functionalized cellulose materials

Researchers from Northeastern University have developed a new, more cost-effective method for immobilizing SARS-CoV-2.

10 Jan 2022

NYBC discovers novel small-molecule pancoronavirus fusion inhibitors

New York Blood Center has published a study that reports the discovery of highly potent small molecules with the ability to inhibit COVID-19 in infected individuals.

9 Jan 2022

History of SARS-CoV-2 infection affects longitudinal responses to BNT162b2 vaccine

In a recently published article in the journal Cell Reports, scientists have demonstrated that individuals with or without a history of coronavirus disease 2019 (COVID-19) exhibit differential humoral and cellular immune responses 14 days after receiving mRNA-based COVID-19 vaccine developed by Pfizer/BioNTech. However, at a later time point, the responses become comparable between the two groups.

9 Jan 2022

Blood test plus risk model can accurately determine who may benefit from lung cancer screening

A blood test, combined with a risk model based on an individual's history, more accurately determines who is likely to benefit from lung cancer screening than the current U.S. recommendation, according to a study published today in the Journal of Clinical Oncology led by researchers from The University of Texas MD Anderson Cancer Center.

9 Jan 2022

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

Millions of people around the globe are affected by cancer each year; more than 39% of men and women are diagnosed with cancer during their lifetime.

7 Jan 2022

Vaccinated mothers transfer SARS-CoV-2 antibodies to their breastfed infants

Women vaccinated against COVID-19 transfer SARS-CoV-2 antibodies to their breastfed infants, potentially giving their babies passive immunity against the coronavirus, according to University of Massachusetts Amherst research.

7 Jan 2022

Researchers receive $990,000 grant to study a low-cost way to help patients with Type 2 diabetes

Mental time travel - transporting someone from the present through imagining a personal, positive future event - has been proven to help reduce alcohol, tobacco, and drug use.

7 Jan 2022

Omicron variant found to be much less sensitive to neutralizing antibodies than Delta

The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries.

7 Jan 2022

Booster mRNA vaccination effective in reviving anti-SARS-CoV-2 antibody titers among the elderly

A new study found that a booster dose vaccination against COVID-19 was successful in taking binding. and neutralizing antibodies to levels higher than those observed after the initial double-dose regimen.

7 Jan 2022

Researchers investigate SARS-CoV-2 specific inflammatory response

New research can confirm that while some of the response from monocytes to SARS-CoV-2 is generic to virus infection, most of it SARS-CoV-2 specific, especially proinflammatory responses.

7 Jan 2022

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

London Medical Laboratory warns that its testing reveals nearly one in five people still have insufficient Covid antibodies.

7 Jan 2022

FIND trial: Higher vitamin D intake does not affect mortality or cardiovascular disease, cancer risk

A trial by the University of Eastern Finland found that taking a much higher dose of vitamin D than recommended for five years did not affect total mortality or the incidence of cardiovascular disease or cancer in older men and women.

7 Jan 2022

SARS-CoV-2 Omicron belongs to new antigenic cluster compared to all other VOCs

Researchers investigate SARS-CoV-2 antigenic drift by evaluating the neutralizing activity of sera from patients infected with all five SARS-CoV-2 VOCs.

6 Jan 2022

Scientists assess effectiveness of neutralizing antibodies against seven SARS-CoV-2 variants, including Omicron

Researchers determine the neutralization potency of serum from COVID-19-recovered patients and double-vaccinated individuals against SARS-CoV-2 variants.

6 Jan 2022

Study estimates the global prevalence of dementia in 2050

The number of adults (aged 40 years and older) living with dementia worldwide is expected to nearly triple, from an estimated 57 million in 2019 to 153 million in 2050, due primarily to population growth and population aging.

6 Jan 2022

Model of neuromuscular junction could accelerate new treatments for neuromuscular diseases

The neuromuscular junction - where nerves and muscle fibers meet - is an essential synapse for muscle contraction and movement.

6 Jan 2022

Researchers explore novel strategy to improve the reprogramming efficiency of human fibroblasts

Not too long ago the idea of taking, for instance a skin cell and transforming it into a muscle cell was unthinkable. About 10 years ago, however, revolutionary research showed that it is indeed possible to reprogram differentiated adult cells into other types fully capable of conducting new functions.

6 Jan 2022

Research may pave the way for designing new therapies to combat schistosomiasis

Neglected tropical diseases (NTDs) represent a group of about 20 conditions that affect more than a billion people worldwide.

6 Jan 2022

Switching to smokeless tobacco associated with lower cardiovascular disease risk in smokers

Regular smokers are at heightened risk of developing cardiovascular disease, but crushing the butts in favor of a "smokeless" alternative like chewing tobacco, snuff or tobacco lozenges may go a long way toward bringing the danger down to a more normal level, a new UCLA-led study shows.

6 Jan 2022

Optical sensing can address unmet clinical needs in orthopedic surgery

Knees and hips wear out. Backs and necks become unstable. Fortunately, orthopedic surgeons specialize in musculoskeletal repair.

6 Jan 2022

Blood News and Research

Strategy for capturing SARS-CoV-2 through functionalized cellulose materials

NYBC discovers novel small-molecule pancoronavirus fusion inhibitors

History of SARS-CoV-2 infection affects longitudinal responses to BNT162b2 vaccine

Blood test plus risk model can accurately determine who may benefit from lung cancer screening

Engineering hairy cellulose nanocrystals to capture chemotherapy drugs

Vaccinated mothers transfer SARS-CoV-2 antibodies to their breastfed infants

Researchers receive $990,000 grant to study a low-cost way to help patients with Type 2 diabetes

Omicron variant found to be much less sensitive to neutralizing antibodies than Delta

Booster mRNA vaccination effective in reviving anti-SARS-CoV-2 antibody titers among the elderly

Researchers investigate SARS-CoV-2 specific inflammatory response

Scrapping many Covid testing measures is a grave mistake, says London Medical Laboratory

FIND trial: Higher vitamin D intake does not affect mortality or cardiovascular disease, cancer risk

SARS-CoV-2 Omicron belongs to new antigenic cluster compared to all other VOCs

Scientists assess effectiveness of neutralizing antibodies against seven SARS-CoV-2 variants, including Omicron

Study estimates the global prevalence of dementia in 2050

Model of neuromuscular junction could accelerate new treatments for neuromuscular diseases

Researchers explore novel strategy to improve the reprogramming efficiency of human fibroblasts

Research may pave the way for designing new therapies to combat schistosomiasis

Switching to smokeless tobacco associated with lower cardiovascular disease risk in smokers

Optical sensing can address unmet clinical needs in orthopedic surgery

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News